Cases & Deals

Abbott acquires Visiogen in a $400 million private company merger

Clients Abbott Laboratories

Jones Day advised Abbott Laboratories in the $400 million acquisition of Visiogen, Inc., an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts.

In addition to M&A representation, Jones Day provided antitrust, benefits, healthcare, and IP advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.